Literature DB >> 28070737

In silico analysis of the anti-hypertensive drugs impact on myocardial oxygen balance.

A Guala1,2, D Leone3, A Milan3, L Ridolfi4.   

Abstract

Hypertension is a very common pathology, and its clinical treatment largely relies on different drugs. Some of these drugs exhibit specific protective functions in addition to those resulting from blood pressure reduction. In this work, we study the impact of commonly used anti-hypertensive drugs (RAAS, [Formula: see text] and calcium channel blockers) on myocardial oxygen supply-consumption balance, which plays a crucial role in type 2 myocardial infarction. To this aim, 42 wash-out hypertensive patients were selected, a number of measured data were used to set a validated multi-scale cardiovascular model to subject-specific conditions, and the administration of different drugs was suitably simulated. Our results ascribe the well-known major cardioprotective efficiency of [Formula: see text] blockers compared to other drugs to a positive change of myocardial oxygen balance due to the concomitant: (1) reduction in aortic systolic, diastolic and pulse pressures, (2) decrease in left ventricular work, diastolic cavity pressure and oxygen consumption, (3) increase in coronary flow and (4) ejection efficiency improvement. RAAS blockers share several positive outcomes with [Formula: see text] blockers, although to a reduced extent. In contrast, calcium channel blockers seem to induce some potentially negative effects on the myocardial oxygen balance.

Entities:  

Keywords:  Anti-hypertensive drugs; Aortic pressure; Calcium channel blockers; Coronary circulation; Hypertension; Myocardial oxygen balance; RAAS blockers; blockers

Mesh:

Substances:

Year:  2017        PMID: 28070737     DOI: 10.1007/s10237-017-0871-0

Source DB:  PubMed          Journal:  Biomech Model Mechanobiol        ISSN: 1617-7940


  1 in total

1.  Cardiovascular deconditioning during long-term spaceflight through multiscale modeling.

Authors:  Caterina Gallo; Luca Ridolfi; Stefania Scarsoglio
Journal:  NPJ Microgravity       Date:  2020-10-01       Impact factor: 4.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.